Here's What The FDA Approval Of Keytruda Means For Merck, And For Bristol-Myers
May 11, 2017 at 11:52 AM EDT
This week, the FDA granted approval for Merck & Co., Inc. (NYSE: MRK)’s Keyruda for chemotherapy combination treatment of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.